AppliedVR names accomplished workers’ comp veteran Michael Marsau Executive Director, Workers’ Compensation
18 Junio 2024 - 5:01AM
Business Wire
Marsau, who has over 25 years’ experience with
workers’ compensation companies, is overseeing the RelieVRx®
program launch into the industry.
AppliedVR has appointed Michael Marsau its Executive Director of
Workers’ Compensation. He is overseeing the launch of the company’s
flagship RelieVRx® prescription therapeutic into the workers’
compensation market. In this role, he develops and implements
sales, marketing, and account service strategies for the
AppliedVR’s workers’ comp channel and directs those efforts.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240618401312/en/
Michael Marsau has joined Applied VR as
its Executive Director of Workers' Compensation. He is introducing
AppliedVR's RelieVRx, the first comprehensive, immersive adjunctive
virtual reality treatment for chronic lower back pain to be
FDA-authorized, to the workers' comp community. (Photo: Business
Wire)
“Managing pain and avoiding addiction are major concerns for
payors,” Marsau said. “I am very excited about introducing them to
a non-pharmacological solution for chronic lower back pain.”
Marsau has held executive positions in workers’ compensation
medical management companies for over 25 years, beginning with
Cypress Care, an ancillary care provider that is now part of Optum.
Most recently, he served as Vice President of Pharmacy Solutions
for myMatrixx.
“The RelieVRx program is a game-changer for workers’ comp,”
Marsau said. “This is a self-managed, home-based virtual reality
therapeutic. It’s safe, cost-effective, clinically proven to reduce
chronic lower back pain, and it continues to work after the injured
worker completes the sessions.”
About AppliedVR
AppliedVR is creating a new reality in healthcare. We are
pioneering immersive therapeutics (ITx), a new category of
medicine, to treat intractable health conditions that affect
millions of people around the world. By harnessing the unique
properties of immersive therapeutics, we are developing a
biopsychosocial solution to address biopsychosocial conditions such
as chronic pain and behavioral and mental health disorders.
Ultimately, we believe that everyone should have access to this
transformative therapeutic and collectively, we are the catalyst of
making this dream a shared reality.
Today, our virtual reality-based treatments represent a
comprehensive approach to chronic pain that empowers patients with
an intuitive device they can self-manage at home. AppliedVR’s
RelieVRx is the first VR-based, prescription therapeutic to receive
Breakthrough Therapy Designation and De Novo authorization by the
FDA for chronic lower back pain (CLBP). CLBP affects 45 million
people in the U.S. alone. We are poised to help millions more
through our substantial development pipeline that addresses
additional multi-dimensional conditions.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240618401312/en/
Helen King Patterson, King Knight Communications, 813-690-4787;
helen@kingknight.com